Vancouver, British Columbia / November 13th, 2018 – Tabu Equity Investments Inc. (the “Company”) is pleased to announce that it has begun discussions with MJ Medicine on Summit LLC, of California. Under the proposed agreement, Tabu will acquire the company’s Cathedral City facility, currently under “lease option to buy” by MJ Medicine on Summit. The facility is fully licensed for cannabis production and will be utilized for the production of CBD and THC distillate and isolate.

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Tabu’s periodic filings with Canadian securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should, aware” and similar expressions, are forward-looking statements.